Financials
Income statement
| Fiscal date | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.7B | 1.4B | 562.9M | 816.0M |
| Cost of revenue | 395.8M | 400.1M | 247.2M | 247.8M |
| Gross profit | 1.3B | 1.0B | 315.7M | 568.2M |
| Operating expense | ||||
| Research & development | 760.1M | 977.7M | 1.0B | 1.3B |
| Selling general and admin | 846.4M | 606.6M | 883.9M | 662.1M |
| Other operating expenses | 135.5M | -60.9M | -12.0M | 12.0M |
| Operating income | -1.6B | -1.8B | -2.8B | -2.7B |
| Non operating interest income | ||||
| Income | 33.7M | 6.1M | 39.1M | 20.0M |
| Expense | 177.4M | 186.1M | 193.0M | 200.7M |
| Other income expense | — | — | — | — |
| Pretax income | -2.0B | -2.0B | -4.2B | -3.4B |
| Tax provision | 34.7M | 8.6M | -53.4M | 57.1M |
| Net income | -2.0B | -2.0B | -4.1B | -3.4B |
| Basic EPS | -126 | -124 | -281 | -227 |
| Diluted EPS | -126 | -124 | -281 | -227 |
| Basic average shares | 15.9M | 15.1M | 14.4M | — |
| Diluted average shares | 15.9M | 15.1M | 14.4M | — |
| EBITDA | -1.2B | -1.4B | -2.4B | -2.3B |
| Net income from continuing op. | -2.0B | -2.0B | -4.1B | -3.4B |
| Minority interests | — | 163.8M | 67.4M | 186.5M |
| Preferred stock dividends | — | — | — | — |